Prostate cancer is the most common cancer in men and accounts for the second most cancer deaths among men globally. Most patients with prostate cancer are diagnosed with localized disease and treated with curative intent, so survival rates are high (nearly 100%). However, almost 10% of patients will present with metastatic disease; these patients have a poor prognosis and a 5-year survival of approximately 30%.

Enjoying our latest content?
Log in or create an account to continue

  • Access the most recent journalism from Nature's award-winning team
  • Explore the latest features & opinion covering groundbreaking research
Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD